CCAR2-regulated superenhancers are enriched with TCF4/LEF1-binding motifs, and their target genes are enriched in pathways associated with CRC progression and are highly expressed in CRC tissues compared with normal colon tissues. Here, TCF4 is linked to colorectal carcinoma.